Navigation Links
Life on Mars 'pregnancy test' successfully launched
Date:9/22/2007

Washington DC*-- Key components of a new approach to discover life on Mars were successfully launched into space Friday as part of a twelve-day, low-Earth orbit experiment to assess their survivability in the space radiation environmenta prelude future journeys to Mars.

The new approach is based on technology similar to that used in pregnancy test kits. The so-called immunoassays are embodied in the Life Marker Chip (LMC) experiment, which has the potential to detect trace levels of biomarkers in the Martian environment. Biomarkers are molecular fingerprints that indicate if life currently is, or ever was, present on Mars. The LMC experiment has been proposed for the European Space Agencys ExoMars rover mission, which is planned for launch in 2013. The LMC experiment is in the development phase and is led by an international consortium with researchers including Andrew Steele, a staff member of Carnegies Geophysical Laboratory in the United States, and scientists from the United Kingdom, The Netherlands, and Germany.

For the current mission, the consortium developed a tiny component, measuring only 1.5 inches x 1.6 inches x .5 inch ( 3.8 cm x 4.1 cm x 1.3 cm) and housing over 2000 samples, to test that the key molecular components to be used in the LMC technology can survive the rigors of space.

The experiment was launched from Baikonur Cosmodrome in Kazakhstan as part of the European Space Agencys BIOPAN-6 experiment platform. The LMC components will experience both weightlessness and the harsh space radiation environment while orbiting the Earth 180 times at an altitude of up to 190 miles (308 km) during the 11.8 day mission.

The BIOPAN-6 platform is mounted on the outside of an un-manned Russian FOTON spacecraft. Once in space the BIOPAN-6 platform will open to expose its contents directly to the space environment, testing both their resistance to space radiation and the space vacuum, before closing and returning to Earth on September 25th. The LMC components will then be taken back to laboratories in the United Kingdom and the United States to analyze the effect of the space flight.

The lead members of the consortium involved in the current mission are Deutsches Zentrum fr Luft- und Raumfahrt (DLR) (Germany), Cranfield University (UK), Carnegie Institution of Washington (USA) and University of Leicester (UK).

Dr. Andrew Steele from the Carnegie Institution of Washington (USA) and one of the initial experiment proposers said, in the USA we are currently flying related technology and components within the protected environment of the International Space Station (ISS) but this will be the first time that these types of materials will have flown unprotected in space in a manner similar to a flight to Mars.

Dr. Lutz Richter of DLR (Germany) and the principal investigator for the current experiment said, This experiment is the culmination of a number of years of hard work and ground based tests to prove the viability of the LMC technology.

Dr. David Cullen, from Cranfield University (UK) and who leads the scientific input into the current experiment, said, ?this will be our first space experiment to demonstrate our belief that immunoassay technology will have an important future role in space exploration and the search for life elsewhere in the Solar System.

Dr. Mark Sims from the University of Leicester (UK) and who heads the overall LMC project said, this mission will be an important stepping stone in our ultimate goal of putting a LMC experiment on the surface of Mars and using it to search for evidence of Life.


'/>"/>

Contact: Andrew Steele
a.steele@gl.ciw.edu
202-478-8974
Carnegie Institution
Source:Eurekalert

Related biology technology :

1. Reliable Assessment of Micronuclei for Genotoxicity Testing in Mice or Rats
2. Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal Performance
3. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
4. PatchMan - Test Report
5. Rapid hit confirmation and early hERG liability testing using the IonWorks HT system
6. Test More siRNAs for Less
7. The Fastest, Simplest, and Most Effective Way to Remove DNA Contamination
8. A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis
9. Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C
10. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
11. Protein Truncation Tests Using the DCode System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 18, 2017 Acupath Laboratories, ... announces the formation of an Executive Committee that will ... beyond. John Cucci , a 15-year ... from Director of Business Development to Chief Sales ... Mr. Cucci served in senior sales leadership roles at ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 According to ... Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, ... market is expected to reach USD 739.9 Million by 2021 from USD 557.1 ... Continue Reading ... MarketsandMarkets Logo ...
(Date:1/18/2017)... --  Parent Project Muscular Dystrophy (PPMD) , a nonprofit ... dystrophy (Duchenne) , today announced a $600,000 grant to ... (NJIT) and Talem Technologies (Talem) as part of the ... assist people living with Duchenne. PPMD is funding a ... computer, software, a force sensor and a motor – ...
(Date:1/18/2017)... ... January 18, 2017 , ... Whitehouse ... expertise. Within Albany Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables ... is planned for further growth in 2017. Extractable & Leachable evaluations have become ...
Breaking Biology Technology:
(Date:12/16/2016)... NEW YORK , Dec. 16, 2016 The global ... reach USD 12.14 billion by 2021 from USD 5.31 billion in ... ... market is mainly driven by technological advancements in medical devices, launch ... devices, rising preference for wireless connectivity among healthcare providers, and increasing ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/15/2016)... Dec. 15, 2016 Advancements in ... health wellness and wellbeing (HWW), and security ... three new passenger vehicles begin to feature ... recognition, heart beat monitoring, brain wave monitoring, ... monitoring, and pulse detection. These will be ...
Breaking Biology News(10 mins):